Golden State Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53 | Hold |
3
| – | – | ﹤0.01% | 1557 |
|
|
2025
Q1 | $53 | Hold |
3
| – | – | ﹤0.01% | 1575 |
|
|
2024
Q4 | $89 | Buy |
+3
| New | +$89 | ﹤0.01% | 1487 |
|
|
2021
Q1 | – | Sell |
-1,406
| Closed | -$243K | – | 225 |
|
|
2020
Q4 | $243K | Buy |
1,406
+6
| +0.4% | +$1.04K | 0.07% | 206 |
|
|
2020
Q3 | $156K | Buy |
+1,400
| New | +$156K | 0.05% | 214 |
|
|
2020
Q2 | – | Sell |
-2,800
| Closed | -$189K | – | 652 |
|
|
2020
Q1 | $189K | Buy |
+2,800
| New | +$189K | 0.08% | 161 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$19K | – | 1119 |
|
|
2019
Q1 | $19K | Buy |
+400
| New | +$19K | 0.01% | 642 |
|